NVN Liquidation Inc (NOVNQ)
0.00
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
NVN Liquidation Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | -4.273M |
December 31, 2022 | -12.17M |
September 30, 2022 | -9.839M |
June 30, 2022 | -12.98M |
March 31, 2022 | -0.162M |
December 31, 2021 | -13.28M |
September 30, 2021 | -6.752M |
June 30, 2021 | -4.264M |
March 31, 2021 | -9.535M |
December 31, 2020 | -9.425M |
September 30, 2020 | -8.136M |
June 30, 2020 | -6.357M |
March 31, 2020 | -7.79M |
December 31, 2019 | -8.839M |
September 30, 2019 | -10.50M |
Date | Value |
---|---|
June 30, 2019 | 1.168M |
March 31, 2019 | -2.127M |
December 31, 2018 | -3.987M |
September 30, 2018 | -8.825M |
June 30, 2018 | -7.132M |
March 31, 2018 | -9.788M |
December 31, 2017 | -8.326M |
September 30, 2017 | -8.126M |
June 30, 2017 | -11.03M |
March 31, 2017 | -4.542M |
December 31, 2016 | -19.28M |
September 30, 2016 | -11.38M |
June 30, 2016 | -14.68M |
March 31, 2016 | -10.05M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-13.28M
Minimum
Dec 2021
1.168M
Maximum
Jun 2019
-7.696M
Average
-8.488M
Median
Free Cash Flow (Quarterly) Benchmarks
Cantabio Pharmaceuticals Inc | -- |
Q BioMed Inc | -0.1382M |
Affymax Inc | -- |
Scopus BioPharma Inc | -1.009M |
Statera BioPharma Inc | -- |